http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021515022-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-03001 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-43 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2019-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021515022-A |
| titleOfInvention | Recombinant alkaline phosphatase for use in the treatment of sepsis-related acute kidney injury |
| abstract | The present disclosure relates to the use of alkaline phosphatases, and in particular to improved alkaline phosphatases, such as RecAP, for the prevention, treatment, cure, or amelioration of symptoms of acute kidney injury caused, for example, by sepsis. The present application is a method for maintaining renal function, shortening the duration of renal replacement therapy, increasing creatinine clearance, and reducing the risk of death or SA-AKI of a subject due to sepsis-related acute kidney injury (SA-AKI). Regarding. |
| priorityDate | 2018-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 223.